• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类催乳素瘤中存在动脉的形态学证据。

Morphological evidence for the presence of arteries in human prolactinomas.

作者信息

Schechter J, Goldsmith P, Wilson C, Weiner R

机构信息

Department of Anatomy and Cell Biology, University of Southern California School of Medicine, Los Angeles 90033.

出版信息

J Clin Endocrinol Metab. 1988 Oct;67(4):713-9. doi: 10.1210/jcem-67-4-713.

DOI:10.1210/jcem-67-4-713
PMID:3417848
Abstract

This study was undertaken to clarify the vascular anatomy of human prolactinomas and specifically to determine whether arteries were present. Sixteen prolactinomas were studied by electron microscopy. The presurgical diagnosis of the tumors as prolactinomas was based on the findings of hyperprolactinemia and radiographic abnormalities, and was confirmed by the electron microscopic features of the specimens as well as by immunocytochemical staining for PRL. In addition to the presence of fenestrated endothelial cells, which are characteristic of the normal capillaries of the anterior pituitary, 13 of the 16 prolactinomas contained arteries. These arteries ranged from well formed vessels with multiple layers of smooth muscle cells to abnormal terminal arterioles, i.e. vessels with fenestrated endothelium surrounded by a variable number of smooth muscle cells. Arteries were not found in anterior pituitaries from 8 patients with no pituitary disease. In the prolactinomas, smooth muscle cells also were found, either isolated in the pericapillary connective tissue space or in small cords some distance from the vessel lumen. The results suggest that vascular changes, including arteriogenesis, occur in prolactinomas (and possibly other types of pituitary tumor). The arteries entering the anterior pituitary directly could be congenital or develop during formation of the tumor. An arterial blood supply to a region of the anterior pituitary could result in the escape of that area from hypothalamic regulation, since systemic blood contains negligible levels of hypothalamic hormones. In the case of PRL-secreting cells, which are tonically inhibited by the hypothalamic hormone dopamine, this would result in hypertrophy, hyperplasia, and possibly tumorigenesis.

摘要

本研究旨在阐明人催乳素瘤的血管解剖结构,特别是确定其中是否存在动脉。通过电子显微镜对16例催乳素瘤进行了研究。肿瘤术前诊断为催乳素瘤基于高催乳素血症和影像学异常的发现,并经标本的电子显微镜特征以及PRL免疫细胞化学染色得以证实。除了存在有窗孔的内皮细胞(这是垂体前叶正常毛细血管的特征)外,16例催乳素瘤中有13例含有动脉。这些动脉范围从具有多层平滑肌细胞的结构良好的血管到异常的终末小动脉,即内皮有窗孔且周围有数量不等平滑肌细胞的血管。在8例无垂体疾病患者的垂体前叶中未发现动脉。在催乳素瘤中,还发现了平滑肌细胞,它们要么孤立于毛细血管周围结缔组织间隙中,要么位于距血管腔一定距离的小索状结构中。结果表明,包括动脉生成在内的血管变化发生在催乳素瘤(可能还有其他类型的垂体肿瘤)中。直接进入垂体前叶的动脉可能是先天性的,也可能在肿瘤形成过程中发育形成。垂体前叶某区域的动脉血供应可能导致该区域脱离下丘脑调节,因为全身血液中下丘脑激素的水平可忽略不计。对于受下丘脑激素多巴胺持续性抑制的催乳素分泌细胞而言,这将导致细胞肥大、增生,并可能引发肿瘤形成。

相似文献

1
Morphological evidence for the presence of arteries in human prolactinomas.人类催乳素瘤中存在动脉的形态学证据。
J Clin Endocrinol Metab. 1988 Oct;67(4):713-9. doi: 10.1210/jcem-67-4-713.
2
Microvasculature of human micro- and macroprolactinomas. A morphological study.人类微泌乳素瘤和大泌乳素瘤的微血管系统。一项形态学研究。
Neuroendocrinology. 1986;43(2):159-65. doi: 10.1159/000124523.
3
Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.白血病抑制因子调节催乳素瘤和催乳素细胞中催乳素的分泌。
J Clin Endocrinol Metab. 2003 Feb;88(2):858-63. doi: 10.1210/jc.2002-021281.
4
Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas.抗血管内皮生长因子策略对实验性多巴胺抵抗性泌乳素瘤的抑制作用。
J Pharmacol Exp Ther. 2011 Jun;337(3):766-74. doi: 10.1124/jpet.110.177790. Epub 2011 Mar 15.
5
Normal structural dopamine type 2 receptor gene in prolactin-secreting and other pituitary tumors.催乳素分泌性垂体瘤及其他垂体瘤中正常结构的多巴胺2型受体基因。
J Clin Endocrinol Metab. 1994 Mar;78(3):568-74. doi: 10.1210/jcem.78.3.7907340.
6
Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors.雌激素诱导的分泌催乳素的垂体前叶肿瘤的直接动脉血管化
Proc Natl Acad Sci U S A. 1984 Jul;81(14):4549-53. doi: 10.1073/pnas.81.14.4549.
7
PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.与催乳素细胞多巴胺能调控相关的不同实验性和人催乳素瘤中的PTTG表达
Mol Cancer. 2007 Jan 12;6:4. doi: 10.1186/1476-4598-6-4.
8
Pulsatile prolactin secretion in hyperprolactinemia due to presumed pituitary stalk interruption.
J Clin Endocrinol Metab. 1991 Dec;73(6):1289-93. doi: 10.1210/jcem-73-6-1289.
9
Evidence of abnormal dopaminergic control of prolactin in patients with hypothalamic and pituitary tumors.下丘脑和垂体肿瘤患者催乳素多巴胺能控制异常的证据。
J Med. 1986;17(1):25-39.
10
Clinicopathologic study of 123 cases of prolactin-secreting pituitary adenomas with special reference to multihormone production and clonality of the adenomas.123例泌乳素分泌型垂体腺瘤的临床病理研究,特别关注腺瘤的多激素分泌及克隆性。
Cancer. 2002 Jul 15;95(2):258-66. doi: 10.1002/cncr.10676.

引用本文的文献

1
Factors Influencing Hormone Remission in Growth Hormone-Secreting Pituitary Neuroendocrine Tumors With Residual Tumor: A Retrospective Cohort Study.影响伴有残留肿瘤的生长激素分泌型垂体神经内分泌肿瘤激素缓解的因素:一项回顾性队列研究
CNS Neurosci Ther. 2025 Aug;31(8):e70574. doi: 10.1111/cns.70574.
2
Hemorrhagic PitNets Are Associated with Previous Vascular Events and Result in Worse Endocrine Outcome.出血性垂体神经内分泌肿瘤与既往血管事件相关,且导致更差的内分泌结局。
Cancers (Basel). 2024 Dec 8;16(23):4105. doi: 10.3390/cancers16234105.
3
Coronavirus Disease 2019 and Pituitary Apoplexy: A Single-Center Case Series and Review of the Literature.
新型冠状病毒肺炎与垂体卒中:单中心病例系列研究及文献复习。
World Neurosurg. 2021 Aug;152:e678-e687. doi: 10.1016/j.wneu.2021.06.004. Epub 2021 Jun 12.
4
Heterogeneity of Vascular Endothelial Cells, De Novo Arteriogenesis and Therapeutic Implications in Pancreatic Neuroendocrine Tumors.胰腺神经内分泌肿瘤中血管内皮细胞的异质性、新生血管生成及其治疗意义
J Clin Med. 2019 Nov 14;8(11):1980. doi: 10.3390/jcm8111980.
5
Angiogenesis in pituitary adenomas: human studies and new mutant mouse models.垂体腺瘤中的血管生成:人体研究与新的突变小鼠模型
Int J Endocrinol. 2014;2014:608497. doi: 10.1155/2014/608497. Epub 2014 Nov 18.
6
Invasive giant prolactinoma with loss of therapeutic response to cabergoline: expression of angiogenic markers.对卡麦角林治疗反应丧失的侵袭性巨大催乳素瘤:血管生成标志物的表达
Endocr Pathol. 2009 Spring;20(1):35-40. doi: 10.1007/s12022-009-9057-3.
7
Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors.雌激素诱导泌乳素分泌型垂体瘤形成过程中垂体前叶内皮细胞中血小板反应蛋白-1水平的变化
J Endocrinol. 2007 Feb;192(2):395-403. doi: 10.1677/joe.1.06925.
8
Angiogenesis in prolactinomas: regulation and relationship with tumour behaviour.催乳素瘤中的血管生成:调控及其与肿瘤行为的关系。
Pituitary. 2005;8(1):17-23. doi: 10.1007/s11102-005-5081-6.
9
Vasculature in Nontumorous Hypophyses, Pituitary Adenomas, and Carcinomas: A Quantitative Morphologic Study.非肿瘤性垂体、垂体腺瘤和癌中的脉管系统:一项定量形态学研究
Endocr Pathol. 1995 Summer;6(2):115-124. doi: 10.1007/BF02739874.
10
The role of hormones, growth factors and their receptors in pituitary tumorigenesis.激素、生长因子及其受体在垂体肿瘤发生中的作用。
Brain Pathol. 2001 Jul;11(3):356-70. doi: 10.1111/j.1750-3639.2001.tb00405.x.